✦ LIBER ✦

TCT-249 Glycoprotein IIb/IIIa receptor inhibitors versus bivalirudin in patients with ST-segment elevation myocardial infarction

✍ Scribed by Angerås, Oskar; Ioanes, Dan; Råmunddal, Truls; Omerovic, Elmir

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Administration of Glycoprotein IIb-IIIa

✍ Paul P. Dobesh; Jennifer B. Kasiar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Glycoprotein IIb/IIIa inhibitors: Therap

✍ Kevin R Campbell; Warren Cantor; Michael Sketch; E.Magnus Ohman 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Cost-effectiveness of bivalirudin versus

✍ Schwenkglenks, M.; Toward, T. J.; Plent, S.; Szucs, T. D.; Blackman, D. J.; Baum 📂 Article 📅 2012 🏛 BMJ 🌐 English ⚖ 322 KB

Use of platelet glycoprotein IIb/IIIa in

✍ Eddy S. Lang; Marc Afilalo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Glycoprotein IIb/IIIa inhibitors in pati

✍ Elliott M Antman 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 222 KB

AS-85: Clinical Benefits of Glycoprotein

✍ Doo Sun Sim; Youngkeun Ahn; Myung Ho Jeong; Young Jo Kim; Shung Chull Chae; Taek 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 83 KB